DLA Piper advised Akoya Biosciences on the deal.Akoya Biosciences (Akoya), a leading biotechnology company that specializes in the development and commercialization of spatial biology solutions, announced…
Akoya Biosciences’ $43.5 Million Common Stock Offering
